Drug Pricing Row To Be Long Legal Battle: IPA
  • Gaurav Sarkar
  • Aug 06 2013

August 6: Talking about the drug pricing tussle between drug companies, the regulator and the government, D.G. Shah, Secretary General of the Indian Pharmaceutical Alliance, says, “We have pointed out the areas that need to be looked at immediately to the PMO but have not heard from them,” he says. Shah also denies reports of India discouraging the indigenous pharmaceutical sector.